http://www.vanleeuwenhoeckresearch.com/(c) 2009, Van Leeuwenhoeck Research All rights reserved.5You can subscribe to this RSS Feed to keep updated on the latest news on Van Leeuwenhoeck Research.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/100730/0647229.html?.v=1Fri, 30 Jul 2010 22:03:00 GMTSat, 31 Jul 2010 12:10:56 GMTBiopharmaceutical company Gilead Sciences Inc. said Friday that it has completed the sale of $2.2 billion worth of senior debt, netting proceeds of about $2.17 billion.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/100730/us_gilead_sciences_debt.html?.v=1Fri, 30 Jul 2010 21:49:00 GMTSat, 31 Jul 2010 12:10:56 GMThttp://us.rd.yahoo.com/finance/external/xbwsj/rss/SIG=12u87vg0k/*http%3A//blogs.wsj.com/deals/2010/07/30/what-happened-to-the-sanofi-genzyme-bear-hug-letter/?mod=yahoo_hsFri, 30 Jul 2010 21:42:00 GMTSat, 31 Jul 2010 12:10:56 GMTPharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance with the continued listing standards specified in Sections 1003, and of the NYSE Amex Company Guide, because it has stockholders' equity of less than $2.0 million, $4.0 million and $6.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years, three of its four most recent fiscal years and its five most recent fiscal years, respectively.  http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100730/ph43548.html?.v=1Fri, 30 Jul 2010 21:00:00 GMTSat, 31 Jul 2010 12:10:56 GMTFOSTER CITY, Calif.----Gilead Sciences, Inc. today announced the closing of its sale of $1.1 billion aggregate principal amount of 1.00% convertible senior notes due 2014 and $1.1 billion aggregate principal amount of 1.625% convertible senior notes due 2016 to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended .http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100730/20100730006105.html?.v=1Fri, 30 Jul 2010 20:30:00 GMTSat, 31 Jul 2010 12:10:56 GMTZiopharm Oncology Inc. said Friday that it turned a second-quarter profit on a $14.1 million gain in non-cash warrant income.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/100730/us_earns_ziopharm_oncology.html?.v=1Fri, 30 Jul 2010 20:08:00 GMTSat, 31 Jul 2010 12:10:56 GMTBERKELEY HEIGHTS, N.J.----Genta Incorporated announced today that its Board of Directors has approved a one-for-one hundred reverse stock split of Genta’s common stock, and that the split will be effective with the open of trading on August 2, 2010.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100730/20100730005027.html?.v=1Fri, 30 Jul 2010 20:06:00 GMTSat, 31 Jul 2010 12:10:56 GMTAnadys Pharmaceuticals, Inc. announced today that it will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5, 2010 at 1:15 p.m. EDT .  The conference is being held at the Sheraton New York Hotel & Towers.  Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and its clinical development programs.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100730/la43724.html?.v=1Fri, 30 Jul 2010 20:05:00 GMTSat, 31 Jul 2010 12:10:56 GMTGeron took off by 17% on Friday after the company announced that it will resume testing on its embryonic stem cell-based spinal cord therapy.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/100730/3792_id.html?.v=1Fri, 30 Jul 2010 19:38:00 GMTSat, 31 Jul 2010 12:10:56 GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13bqjeacq/*http%3A//www.fool.com/investing/high-growth/2010/07/30/3-development-stage-drugmakers-worth-watching.aspx?source=eptyholnk303100&logvisit=y&npu=yFri, 30 Jul 2010 19:11:00 GMTSat, 31 Jul 2010 12:10:56 GMTThe price of pride: $5m. If Charles River Laboratories had gone ahead with next week's shareholder vote on its proposed acquisition of Wuxi PharmaTech - which could have been China's biggest inbound takeover yet - it would have had to pay a $25m break fee to Wuxi if the deal was rejected.http://us.rd.yahoo.com/finance/external/ft/rss/SIG=125telb7h/*http%3A//www.ft.com/cms/s/7c6bc560-9c06-11df-a7a4-00144feab49a.html?referrer_id=yahoofinance&ft_ref=yahoo1&segid=03058Fri, 30 Jul 2010 18:55:00 GMTSat, 31 Jul 2010 12:10:56 GMTRegulators on Friday gave the all-clear to a clinical trial that will test embryonic stem cells as a treatment for spinal cord injury, potentially the first time embryonic stem cells are tested on humans.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/100730/us_geron_clinical_trial.html?.v=3Fri, 30 Jul 2010 18:43:00 GMTSat, 31 Jul 2010 12:10:56 GMTThe world's first treatment based on human embryonic stem cells is set to begin a clinical trial within the next two months, in patients with acute spinal cord injury.http://us.rd.yahoo.com/finance/external/ft/rss/SIG=1258tiipr/*http%3A//www.ft.com/cms/s/322baf24-9c01-11df-a7a4-00144feab49a.html?referrer_id=yahoofinance&ft_ref=yahoo1&segid=03058Fri, 30 Jul 2010 18:30:00 GMTSat, 31 Jul 2010 12:10:56 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/100730/0647130.html?.v=1Fri, 30 Jul 2010 18:11:00 GMTSat, 31 Jul 2010 12:10:56 GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13cfntq5e/*http%3A//www.fool.com/investing/general/2010/07/30/regeneron-pharmaceuticals-warming-up-or-cooling-of.aspx?source=eptyholnk303100&logvisit=y&npu=yFri, 30 Jul 2010 17:33:00 GMTSat, 31 Jul 2010 12:10:56 GMT